Avid Bioservices Inc (CDMO)

[sulaco]

Great work, Mass - GILD has 7,000 employees and a $146B market cap

while MRK has 77,000 employees and (a lower) $144B market cap. Whoa.


GILD CEO John Martin is quoted thus:

I hope in my lifetime we have neither the culture, nor the number of employees, of Merck

GILD remains lean, mean, entrepeneurial, and not-at-all hesitant to seek answers OUTSIDE their company.

The critical interface for communication between the immune system and a cancerous cell is the cell membrane. PS signaling in the phospholipid bilayer, a crucial checkpoint for immune deactivation, can be short-circuited by a certain monoclonal antibody, namely, Bavituximab.

If GILD scientists, the best bunch out there, identify Bavi as their cornerstone molecule, then it's "lights out" for anyone who holds PPHM stock.

Regards,

Joe